“…14 In addition, 4 meta-analyses and one systematic review have been published in an attempt to obtain enough data (and statistical power) to draw definitive conclusions as to voice outcomes. 7,[10][11][12][13] The only currently published prospective, randomized study directly comparing voice outcomes between TLM and RT for early glottic cancer included 60 patients, 31 in the TLM group and 25 in the RT group, all treated for T1a glottic carcinoma. 14 At 2 years posttreatment, patient-rated "hoarseness" did not differ between the 2 groups (43/100 vs 35/100 on a visual analog scale of 0-100) but "impact on everyday life" was significantly higher in the TLM group (32/11 vs 8/100).…”